Skip to main content

Be a Marine Mammal Hero

Hungry pups like elephant seal Davey are pouring through our doors. Yes, we are in the swing of pupping season, and that’s why your help is urgently needed.

What if I told you there’s a simple way you can have double the impact for good?

Today, your gift will help provide what a pup like Davey needs: double the fish meals to regain his strength for a second chance at life. How? Because your gift will be matched dollar-for-dollar up to $5,000 when you give by Sunday, June 1.

Double my impact!
Elephant seal pup, Davey
harbor seal

Comparative pharmacokinetics of a single oral dose of meloxicam in the California sea lion and Pacific harbor seal

Comparative pharmacokinetics of a single oral dose of meloxicam in the California sea lion (Zalophus californianus) and Pacific harbor seal (Phoca vitulina richardii)
  • Medicine

Abstract

Pharmacokinetics studies have investigated meloxicam, a non-steroidal antiinflammatory drug, dosing strategies in a wide variety of non-domestic animals; however, there is no prior study examining well-founded dosing for pinnipeds. To develop dosing protocols, pharmacokinetic information is needed, with an examination of differences between pinniped species. Apparently, healthy California sea lions (Zalophus californianus: CSL; n= 13) and Pacific harbor seals (Phoca vitulina richardii: PHS; n= 17) that had completed rehabilitation were enrolled into a population-based pharmacokinetic study. Each animal was administered a single oral dose of meloxicam at 0.1 mg/ kg, and two blood samples were collected from each animal at varying intervals during a 96-h study period. Plasma concentrations of meloxicam were determined by high-pressure liquid chromatography. Data were analyzed with nonlinear mixed effects modeling (Phoenix® NLME™, Certara, St. Louis, MO 63105, USA). The results indicated that in PHS, peak plasma concentration (Cmax) was 0.33 μg/mL with an elimination half-life (Ke t½) of 31.53 h. In CSL, Cmax was 0.17 μg/mL with Ke t½ of 32.71 h. All animals enrolled completed the study without outward adverse clinical signs. The elimination half-life was longer than previously recommended dosing intervals for pinnipeds; however, we cannot speculate in the optimum clinical dose from these results.


Trumbull, E.J., Papich, M.G., Peters, M., Whitmer, E.R., Rivard, M. and Field, C.L., 2024. Comparative pharmacokinetics of a single oral dose of meloxicam in the California sea lion (Zalophus californianus) and Pacific harbor seal (Phoca vitulina richardii). Journal of Veterinary Pharmacology and Therapeutics, 47(6), pp.485-491.

medicine
Cara Field
Emily Whitmer
medicine, pharmacokinetics, California sea lion, Pacific harbor seal, dosing, meloxicam

Meet The Experts

Related Publications

Related News